Description
A phenylalkylamine L-type calcium channel blocker; blocks recombinant rat L-type calcium channels expressed in tsA201 cells (IC50s = 782 and 8,000 nM at holding potentials of 10 and -60 mV, respectively); blocks maitotoxin-induced calcium influx in NIH3T3 fibroblast cells (IC50 = 16 μM); inhibits histamine-induced acid secretion by primary enriched guinea pig parietal cells (IC50 = 10.9 μM); binds to rat myocardial membranes (IC50 = 16 nM); inhibits electrically-stimulated contractions in rat right myocardial ventricular strips (EC50 = 1.95 μM); decreases blood pressure and inhibits uterine contractions in conscious, ovariectomized, post-partum rats (204 and 324 μg/kg, respectively)
Formal name: α-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4,5-trimethoxy-α-(1-methylethyl)-benzeneacetonitrile, monohydrochloride
Synonyms: Gallopamil|NSC 274966
Molecular weight: 521.1
CAS: 16662-46-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ion Channel Modulation|Blockers||Research Area|Cardiovascular System|Heart|Myocardial Contractility||Research Area|Cardiovascular System|Vasculature|Vasodilation||Research Area|Endocrinology & Metabolism|Reproductive Biology